Procter & Gamble Hygiene & Health Care’s total income in Q4FY23 fell 8% to ₹ 898 crores. Consolidated Profit After Tax came
Procter & Gamble Hygiene & Health Care Q4FY23; 3% Fall in Profits
Categories
Healthcare
Jyothy Laboratories Limited (JYOTHYLAB) Q4 FY23 Earnings Concall Transcript
Jyothy Laboratories Limited (NSE:JYOTHYLAB) Q4 FY23 Earnings Concall dated May. 03, 2023. Corporate Participants: Sanjay Agarwal -- Chief Financial Officer M R Jyothy -- Managing Director
Aarti Drugs Limited (AARTIDRUGS) Q4 FY23 Earnings Concall Transcript
Aarti Drugs Limited (NSE:AARTIDRUGS) Q4 FY23 Earnings Concall dated May. 02, 2023. Corporate Participants: Adhish Patil -- Chief Financial Officer Harshit M. Savla -- Joint Managing
Dhampur Bio Organics Ltd (DBOL) Q4 FY23 Earnings Concall Transcript
Dhampur Bio Organics Ltd (NSE:DBOL) Q4 FY23 Earnings Concall dated Apr. 27, 2023. Corporate Participants: Mr. Navin Agrawal -- Head of Institutional Equities Nalin
Glenmark Pharmaceuticals: An Uphill Battle
“Strategic priority is to enhance our free cash generation and further debt reduction and we continue discussion with potential partners for out-licensing
Sequent Scientific Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Sequent Scientific Limited (SEQUENT) Q3 FY23 Earnings Concall Management Update: [00:05:37] SEQUENT said that in the API business, the
The Revival of Amrutanjan Healthcare Limited
Amrutanjan’s flagship yellow headache balm is possibly its most successful product. It is also among the first products that the company launched.
Earnings Summary Of Krishna Institute of Medical Sciences Limited For Q3 FY23
KIMS is known for providing high-quality healthcare services across various specialties such as cardiology, oncology, orthopedics, neurology, and gastroenterology. The company's hospitals
Star Health & Allied Insurance Limited Q3FY23
With a market share of 15.8 percent in the Indian health insurance industry in FY21 and leading in the lucrative retail health
Rainbow Children’s Medicare Q3FY23 Earnings
An Indian hospital network with many specialties in paediatrics, obstetrics, and gynaecology is run by Rainbow Children's Medicare Limited. The business provides
Procter & Gamble Hygiene & Health Care Q2FY23 Earnings Story
In the femcare and healthcare industries, Procter & Gamble Hygiene and Health Care Ltd manufactures and sells branded packaged FMCG. Its portfolio
Metropolis Healthcare Limited Q3FY23 Earnings
Metropolis Healthcare Limited is among the leading diagnostic companies in India. The company has a great geographical presence across nations including India,
Earnings Summary Of Fortis Healthcare Limited For Q3 FY23
Fortis Healthcare Limited (NSE: FORTIS) is one of India's leading healthcare providers, offering a range of medical services across its network of
Max Healthcare Inst. Limited Q3FY23 Earnings
Primary care clinics, multi-specialty hospitals / medical centres, and super-specialty hospitals are the main venues through which Max Healthcare Institute Limited offers
Orchid Pharma Ltd (ORCHPHARMA) Q3 FY23 Earnings Concall Transcript
Orchid Pharma Ltd (NSE: ORCHPHARMA) Q3 FY23 Earnings Concall dated Feb. 17, 2023 Corporate Participants: Manish Dhanuka -- Managing Director Mridul Dhanuka -- Executive Director Sunil
Shilpa Medicare Ltd (SHILPAMED) Q3 FY23 Earnings Concall Transcript
Shilpa Medicare Ltd (NSE: SHILPAMED) Q3 FY23 Earnings Concall dated Feb. 15, 2023 Corporate Participants: Vishnukanth Bhutada -- Managing Director Alpesh Dalal -- Chief Financial Officer
Aster DM Healthcare Limited (ASTERDM) Q3 FY23 Earnings Concall Transcript
Aster DM Healthcare Limited (NSE:ASTERDM) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Azad Moopen -- Chairman and Managing Director Alisha Moopen -- Deputy
Fortis Healthcare Ltd (FORTIS) Q3 FY23 Earnings Concall Transcript
Fortis Healthcare Ltd (NSE:FORTIS) Q3 FY23 Earnings Concall dated Feb. 13, 2023. Corporate Participants: Anurag Kalra -- Senior Vice President, Investor Relations Ashutosh Raghuvanshi -- Managing
Lupin Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Management Update: [00:03:30] LUPIN said it is optimistic of growing its US
Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Transcript
Lupin Ltd (NSE:LUPIN) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh Swaminathan -- Executive Director, Global Chief
Aurobindo Pharma Limited (AUROPHARMA) Q3 FY23 Earnings Concall Transcript
Aurobindo Pharma Limited (NSE:AUROPHARMA) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Deepti Thakur -- Investor Relations Santhanam Subramanian -- Chief Financial Officer Satakarni